Rojas, MonicaLución, MariaBecker, RicardoLuevanos, AntonioGutierrez, IvanEstripeaut, DoraSchilling Redlich, AndreaWebster, JessicaPerez, MariaHirata, LucianaOrengo, JuanParellada, Cintia2026-08-252026-08-252025Rojas M, Florencia Lución M, Becker Feijó R, Luevanos A, Gutierrez Tobar IF, Estripeaut D, Schilling A, Webster J, Eugenia Perez M, Hirata L, Orengo JC, Irene Parellada C. Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature. Hum Vaccin Immunother. 2025 Dec;21(1):2528403. doi: 10.1080/21645515.2025.2528403https://hdl.handle.net/11447/11037This review aimed to characterize adolescent vaccination schedules in publicly funded national immunization programs in Latin America and the Caribbean. The initial review identified vaccine type, target age and gender, dose schedule, and vaccination coverage rate (VCR) across 50 countries/territories in the region. A systematic review from January 2010-October 2023 was then conducted to identify primary data collection studies reporting VCRs. Overall, 42 webpages and 23 primary studies were identified. Among 47 countries/territories with ≥1 vaccine for adolescent immunization, human papillomavirus (HPV) vaccine was included in 45, tetanus component vaccines in 43, and meningococcal vaccines in 10. Catch-up vaccination for hepatitis B in 17, and yellow fever in all 13 endemic countries/territories. VCRs were primarily available for HPV. The findings of this review underscore the need to prioritize adolescent vaccination, improve accessibility, and strengthen tracking infrastructure to ensure comprehensive protection of this age group across the region.enAdolescentLatin America and CaribbeanImmunizationVaccination coverageVaccine uptakeVaccinesArticlehttps://doi.org/10.1080/21645515.2025.2528403